ATMPsBusiness ModelEconomicsCTGCTUCLGregor Cuzak 12 February 2025 Introduction to IP and commercialisation – by UCL The workshop took place on February 3d and was attended by the CTGCT advanced partners only. It provided an in-depth discussion on Intellectual Property (IP) and the process of commercializing research findings. The session ... More
EventsResearchersCell therapyGen TherapyBusiness ModelEconomicsCTGCTNICRodrigo Ortiz 23 October 2024 Event Date: 9 October 2024 • 09:00 do: 11 October 2024 • 16:00 3rd Teaming Club Conference – Novi Sad The CTGCT presented the project in the 3rd Teaming Club Conference in Novi Sad, Serbia. More
EventsCliniciansPacientsResearchersATMPsCell therapyGen TherapyBusiness ModelDrug DiscoveryEconomicsInvestmentMarketaccessRegulationResearchCTGCTGregor Cuzak 12 September 2024 Event Date: 6 September 2024 • 09:00 do: 6 September 2024 • European Commission Hosts Sixth Regional HTA Event in Budapest The European Commission recently held its sixth regional event in Budapest, focusing on the upcoming Health Technology Assessment (HTA) regulation. Set to launch in January 2025, this new framework aims to streamline the evaluation ... More
CliniciansResearchersCell therapyGen TherapyGMPBusiness ModelClinic studyDrug DiscoveryEconomicsInvestmentLogisticsPre ClinicalResearchCTGCTNICUCLGregor Cuzak 17 July 2024 UCL ATMP Pipeline Our partner University College London (UCL) have produced a great short brochure (link) showing the strength and depth of their pipeline of ATMPs. They use a managed portfolio approach in which they support ~100 ... More
CliniciansPacientsResearchersBusiness ModelCharite BerlinCTGCTNICUCLUMCUtrechtGregor Cuzak 8 July 2024 The Promise and Price of Advanced Therapies Here’s what Claude Sonnet 3.5 has to answer when we question it: why do ATMPs cost so much? Advanced Therapy Medicinal Products (ATMPs), including gene and cell therapies, represent a revolutionary frontier in medicine, ... More
